Plain-English translation of NCT07351045 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called enicepatide to help people with obesity or overweight manage their weight. Enicepatide works by mimicking natural hormones in your body that help control hunger and weight. Researchers want to compare this medication to a placebo (a dummy injection) to see if it safely helps people lose weight.
Many people struggle to lose weight through diet and exercise alone, and current weight-loss options are limited. This trial exists to see if this medication could offer a new, effective treatment choice for people dealing with obesity or related health problems like high blood pressure or sleep apnea.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the new medication or a placebo injection once per week. You will visit the research clinic regularly for check-ups, blood tests, and weight measurements to see how the treatment is working and ensure it is safe. The study involves comparing three different doses of the medication against placebo, with about 2,000 participants total, so researchers can find the best dose that works.
AI-generated summary from trial data · Oct 4, 2026 · Not medical advice
United States